Ofatumumab

Ofatumumab
Description

Product Description

Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation

 

 

[accordions]
[accordion title= “Chemical Properties“]

Molecular Weight 149 kDa
CAS No. 679818-59-8

[/accordion]

 

 

 

[accordions]
[accordion title= “References and Literature“]

1. Barth MJ, et al.Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma.Clin Cancer Res. 2015 Oct 1;21(19):4391-7.

[/accordion]